[Intratympanic dexamethasone injections for intractable sudden sensorineural hearing loss].
OBJECTIVE
To investigate the efficacy of intratympanic dexamethasone injection (IDI) for 23 patients with intractable sudden sensorineural hearing loss (SSNHL).


METHODS
Dexamethasone (5 g/ml) was injected into the middle ear. The injection was repeated once two days and had a total of 4 doses (10 mg).


RESULTS
The 23 patients were followed up for one month. Eight of 23 patients (34.8%) demonstrated a 17 to approximately 54 dB improvement in PTA and 15 of 23 (65.2%) had no response.


CONCLUSIONS
IDI is a simple and effective treatment for SSNHL patient who had not responded to conventional therapy, although hearing was rarely improved to normal levels.
Ren
Jihao
J
Department of Otolaryngology, the Second Hospital of Xiangya Medical College, Central South University, Changsha, 410011, China. lihao5114@sina.com
Lu
Yongde
Y
Yin
Tuanfang
T
Liu
Bin
B
Ge
Yilin
Y
D000328:Adult; D000368:Aged; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004432:Ear, Middle; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged
D003907:Dexamethasone